GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $70,590 | -69.4% | 36,200 | -56.3% | 0.00% | -100.0% |
| Q1 2023 | $230,462 | -67.5% | 82,900 | -59.7% | 0.00% | -50.0% |
| Q4 2022 | $709,682 | +21.1% | 205,705 | -9.8% | 0.00% | 0.0% |
| Q3 2022 | $586,000 | +41.5% | 227,944 | +33.2% | 0.00% | +100.0% |
| Q2 2022 | $414,000 | +216.0% | 171,104 | +438.9% | 0.00% | – |
| Q1 2022 | $131,000 | -96.4% | 31,753 | -92.0% | 0.00% | -100.0% |
| Q2 2021 | $3,621,000 | +58.3% | 396,659 | +63.5% | 0.01% | +33.3% |
| Q1 2021 | $2,288,000 | +208.4% | 242,599 | +117.1% | 0.01% | +50.0% |
| Q2 2020 | $742,000 | +466.4% | 111,760 | +395.7% | 0.00% | +300.0% |
| Q1 2020 | $131,000 | -7.1% | 22,548 | +43.2% | 0.00% | – |
| Q4 2019 | $141,000 | -30.5% | 15,750 | -13.5% | 0.00% | -100.0% |
| Q2 2019 | $203,000 | – | 18,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |